Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Embryo Defragmentation on Day 4 (D4) on Blastocyst Development Rate and Clinical Outcomes in ART Cycles: a Prospective RCT

NCT07500337 is registered in ClinicalTrials.gov with Momo Fertilife as lead sponsor.

NCT NCT07500337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07500337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Embryo Defragmentation on Day 4 (D4) on Blastocyst Development Rate and Clinical Outcomes in ART Cycles: a Prospective RCT
Lead sponsor
Momo Fertilife
Phase
Not applicable
Overall status
Recruiting
Start date
March 24, 2026
Completion date
December 31, 2026
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

embryo development, female infertility, in vitro fertilization